Member Info for winnings1

Up 2% on Dhaka stock exchange today. Shares here at half price of Dhaka price. Are investors in Dhaka stupid to pay double the price for the BXP shares there just because they have votinG rights (which most private investors never bother with).
The more BXP gains momentum, global reputation and global market share, the narrower the gap between the two share prices will become.

Jolly - Divi 3.5p, after withholding tax 2.9p and that makes it almost 6% Net on share price 50p. Sell away if you like, but I am in for the long term, to witness the company grow in Sales and Profits and consequently a narrowing in the share price difference between here an Dhaka

Net Dividend now close on 6% at current low share price.
Not bad for a fast growing pharmaceutical company.

Justthisonce - I had a good look at the accounts and now understand that the £7.9 million
loss-provision has been added back to underlying profit, i.e. thus enhancing underlying E.P.S.
All quite correct I daresay.

Thanks for correcting me.

I may be entirely wrong, but in my view the word ‘provision’ as used in the 2021 accounts, does not mean the amount has been deducted from the year’s profit, but remains a provision for eventual loss of the £7.9 million case, i.e. not deducted from profit until the case is settled. But please correct me where I am wrong.

I am not sure on this, but setting the money aside does not register it as a loss? Can anyone clarify?

Perhaps not quite so strange. CEO Butterfield stepping back causes uncertainty. The potential fine of £10 million hanging over the Company (of concern to Butterfield) could wipe out net profits for a whole year, thus compounded uncertainty.
I sold out quite some time ago when I felt that the £10 million fine would be unescapable, I followed my gut-feelings, although I might be proven wrong.
High risk territory here for the time being, IMHO.

Then there is still the unresolved legal case, with £10 million fine still a possibility.
In case anyone is interested, Beximco Pharmaceuticals (BXP) looks a buy-opportuninty at current unjustied bagain basement prkice.

Hi Jolly - Filling your boots yet? Topping up opportunity if ever there was!

Jolly - 70% / erratic, momentarily, short duration.
BXP is now a seriously well respected Company, globally recognised as a worthy player in the pharmaceutical field. Entrusted by the Bangladesh Government with the national distribution of Covid vaccine. Profits and EPS rising nicely. Current EPS 10p, which is 150% up on 10 years ago. What is there not to like!

Looks like the share price is comfortably heading towards my earlier stated target price of 140-150p. Should be there before the end of this year, IMHO.
Meantime my interest is currently directed at Beximco Pharmaceuticals (BXP) where the share price is just now remarkably low, indeed undeservedly low, imho.

Jolly - As and when a Company becomes more established, the discount on no-voting-rights shares narrows to as little as a few percentage points, indeed I believe there have been instances of a small premium over voting shares for short durations.

Jolly - An example of 97% discount please? I it exists or has existed then it would be for a bankrupt company, but please lety us have an example.

Does anyone here own Beximco Pharmaceutical shares (BXP), the shares have gone down to a silly
low level, trading now at about half the price of the same shares in the Dhaka Srock Exchange, the
only difference being that the share here have no voting rights, but Dividend (3.5p this year)
the same. Worth a look I would say. IMHO.

BXP up almost 3% today on Dhaka stock exchange.

I do n't quite share your optimism, I mean your optimism about UK. Not so may weeks ago we were sinking rapidly.
Thankfully things have improved since then. I share you optimism about Bangladesh though, - a country in the making!

If we don't pull our socks up, then our own country could be viewed as a 'basketcase' some day.

Jolly - If you feel uncomfortable about Bangladesh, if you do not trust management of BXP, if you don't feel happy
about the shares here having no voting rights, then would it not be wise to look elsewhere for you investments.
As for voting rights - I never vote, never anyehwere, and to be honest I do not think many private investors do ever
do cast their vote, anywhere.
Cheers.

Earning per share (EPS) up by 150% in 10 years (since 2012).